{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T20:29:45Z","timestamp":1784406585062,"version":"3.55.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T00:00:00Z","timestamp":1743811200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1007\/s10620-025-08982-4","type":"journal-article","created":{"date-parts":[[2025,4,5]],"date-time":"2025-04-05T23:05:47Z","timestamp":1743894347000},"page":"2414-2425","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of Acute Severe Ulcerative Colitis Predictors for Steroid Therapy Refractoriness"],"prefix":"10.1007","volume":"70","author":[{"given":"Alaa","family":"Abdelmeguid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amany Ahmed","family":"El Banna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wafaa","family":"Elsheikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Ismail","family":"Ellakany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaji","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,5]]},"reference":[{"key":"8982_CR1","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1093\/ecco-jcc\/jjy154","volume":"13","author":"J Burisch","year":"2019","unstructured":"Burisch J, Katsanos KH, Christodoulou DK, Barros L, Magro F, Pedersen N et al. Natural disease course of ulcerative colitis during the first five years of follow-up in a european population-based inception cohort-an Epi-IBD study. J Crohns Colitis. 2019;13:198\u2013208.","journal-title":"J Crohns Colitis"},{"key":"8982_CR2","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1016\/j.crohns.2010.02.001","volume":"4","author":"LC Dinesen","year":"2010","unstructured":"Dinesen LC, Walsh AJ, Protic MN, Heap G, Cummings F, Warren BF et al. The pattern and outcome of acute severe colitis. J Crohns Colitis. 2010;4:431\u2013437.","journal-title":"J Crohns Colitis"},{"key":"8982_CR3","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/apt.15592","volume":"51","author":"C Dong","year":"2020","unstructured":"Dong C, Metzger M, Holsb\u00f8 E, Perduca V, Carbonnel F. Systematic review with meta-analysis: mortality in acute severe ulcerative colitis. Aliment Pharmacol Ther. 2020;51:8\u201333.","journal-title":"Aliment Pharmacol Ther"},{"key":"8982_CR4","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1136\/bmj.2.4947.1041","volume":"2","author":"SC Truelove","year":"1955","unstructured":"Truelove SC, Witts LJ. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955;2:1041\u20131048.","journal-title":"Br Med J"},{"key":"8982_CR5","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","volume":"11","author":"F Magro","year":"2017","unstructured":"Magro F, Gionchetti P, Eliakim R, Ardizzone S, Armuzzi A, Barreiro-de Acosta M et al. Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: Definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders. J Crohns Colitis. 2017;11:649\u2013670.","journal-title":"J Crohns Colitis."},{"key":"8982_CR6","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1111\/apt.12473","volume":"38","author":"RW Lynch","year":"2013","unstructured":"Lynch RW, Lowe D, Protheroe A, Driscoll R, Rhodes JM, Arnott ID. Outcomes of rescue therapy in acute severe ulcerative colitis: data from the United Kingdom inflammatory bowel disease audit. Aliment Pharmacol Ther. 2013;38:935\u2013945.","journal-title":"Aliment Pharmacol Ther"},{"key":"8982_CR7","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/S2468-1253(16)30003-6","volume":"1","author":"JG Williams","year":"2016","unstructured":"Williams JG, Alam MF, Alrubaiy L, Arnott I, Clement C, Cohen D et al. Infliximab versus ciclosporin for steroid-resistant acute severe ulcerative colitis (CONSTRUCT): a mixed methods, open-label, pragmatic randomised trial. Lancet Gastroenterol Hepatol. 2016;1:15\u201324.","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"8982_CR8","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1093\/ibd\/izaa088","volume":"27","author":"RK Grant","year":"2021","unstructured":"Grant RK, Jones GR, Plevris N, Lynch RW, Jenkinson PW, Lees CW et al. The ACE (albumin, CRP and endoscopy) index in acute colitis: a simple clinical index on admission that predicts outcome in patients with acute ulcerative colitis. Inflamm Bowel Dis. 2021;27:451\u2013457.","journal-title":"Inflamm Bowel Dis"},{"key":"8982_CR9","doi-asserted-by":"publisher","first-page":"s1","DOI":"10.1136\/gutjnl-2019-318484","volume":"68","author":"CA Lamb","year":"2019","unstructured":"Lamb CA, Kennedy NA, Raine T, Hendy PA, Smith PJ, Limdi JK et al. British Society of Gastroenterology consensus guidelines on the management of inflammatory bowel disease in adults. Gut 2019;68:s1\u2013s106.","journal-title":"Gut"},{"key":"8982_CR10","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1093\/ecco-jcc\/jjab177","volume":"16","author":"A Spinelli","year":"2022","unstructured":"Spinelli A, Bonovas S, Burisch J, Kucharzik T, Adamina M, Annese V et al. ECCO guidelines on therapeutics in ulcerative colitis: surgical treatment. J Crohns Colitis. 2022;16:179\u2013189.","journal-title":"J Crohns Colitis"},{"key":"8982_CR11","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1016\/j.cgh.2006.09.033","volume":"5","author":"D Turner","year":"2007","unstructured":"Turner D, Walsh CM, Steinhart AH, Griffiths AM. Response to corticosteroids in severe ulcerative colitis: a systematic review of the literature and a meta-regression. Clin Gastroenterol Hepatol. 2007;5:103\u2013110.","journal-title":"Clin Gastroenterol Hepatol"},{"key":"8982_CR12","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1136\/gut.38.6.905","volume":"38","author":"SP Travis","year":"1996","unstructured":"Travis SP, Farrant JM, Ricketts C, Nolan DJ, Mortensen NM, Kettlewell MG et al. Predicting outcome in severe ulcerative colitis. Gut 1996;38:905\u2013910.","journal-title":"Gut"},{"key":"8982_CR13","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1365-2036.2004.01945.x","volume":"19","author":"GT Ho","year":"2004","unstructured":"Ho GT, Mowat C, Goddard CJ, Fennell JM, Shah NB, Prescott RJ et al. Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. Aliment Pharmacol Ther. 2004;19:1079\u20131087.","journal-title":"Aliment Pharmacol Ther"},{"key":"8982_CR14","doi-asserted-by":"publisher","first-page":"831","DOI":"10.1097\/00042737-199810000-00003","volume":"10","author":"SC Lindgren","year":"1998","unstructured":"Lindgren SC, Flood LM, Kilander AF, L\u00f6fberg R, Persson TB, Sj\u00f6dahl RI. Early predictors of glucocorticosteroid treatment failure in severe and moderately severe attacks of ulcerative colitis. Eur J Gastroenterol Hepatol. 1998;10:831\u2013835.","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"8982_CR15","doi-asserted-by":"publisher","first-page":"e48","DOI":"10.1097\/MCG.0000000000000884","volume":"52","author":"DJ Gibson","year":"2018","unstructured":"Gibson DJ, Hartery K, Doherty J, Nolan J, Keegan D, Byrne K et al. CRP\/albumin ratio: an early predictor of steroid responsiveness in acute severe ulcerative colitis. J Clin Gastroenterol. 2018;52:e48\u2013e52.","journal-title":"J Clin Gastroenterol"},{"key":"8982_CR16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1136\/gutjnl-2022-327533","volume":"72","author":"A Adams","year":"2023","unstructured":"Adams A, Gupta V, Mohsen W, Chapman TP, Subhaharan D, Kakkadasam Ramaswamy P et al. Early management of acute severe UC in the biologics era: development and international validation of a prognostic clinical index to predict steroid response. Gut 2023;72:433\u2013442.","journal-title":"Gut"},{"key":"8982_CR17","doi-asserted-by":"publisher","first-page":"921","DOI":"10.1111\/apt.18190","volume":"60","author":"A Croft","year":"2024","unstructured":"Croft A, Okano S, Hartel G, Lord A, Walker G, Tambakis G et al. A personalised algorithm predicting the risk of intravenous corticosteroid failure in acute ulcerative colitis. Aliment Pharmacol Ther. 2024;60:921\u2013933.","journal-title":"Aliment Pharmacol Ther"},{"key":"8982_CR18","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12876-022-02178-0","volume":"22","author":"SB Park","year":"2022","unstructured":"Park SB, Kim SJ, Lee J, Lee YJ, Baek DH, Seo GS et al. Efficacy of sigmoidoscopy for evaluating disease activity in patients with ulcerative colitis. BMC Gastroenterol. 2022;22:83.","journal-title":"BMC Gastroenterol"},{"key":"8982_CR19","doi-asserted-by":"publisher","first-page":"6208","DOI":"10.3748\/wjg.v29.i48.6208","volume":"29","author":"XY Liu","year":"2023","unstructured":"Liu XY, Tian ZB, Zhang LJ, Liu AL, Zhang XF, Wu J et al. Clinical value of the Toronto inflammatory bowel disease global endoscopic reporting score in ulcerative colitis. World J Gastroenterol. 2023;29:6208\u20136221.","journal-title":"World J Gastroenterol"},{"key":"8982_CR20","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1093\/ecco-jcc\/jjv047","volume":"9","author":"C Corte","year":"2015","unstructured":"Corte C, Fernandopulle N, Catuneanu AM, Burger D, Cesarini M, White L et al. Association between the ulcerative colitis endoscopic index of severity (UCEIS) and outcomes in acute severe ulcerative colitis. J Crohns Colitis. 2015;9:376\u2013381.","journal-title":"J Crohns Colitis"},{"key":"8982_CR21","doi-asserted-by":"publisher","first-page":"828","DOI":"10.1111\/imj.15131","volume":"52","author":"A Barnes","year":"2022","unstructured":"Barnes A, Spizzo P, Mountifield R. Corticosteroid exposure prior to admission and predicting need for rescue therapy in acute severe ulcerative colitis. Intern Med J. 2022;52:828\u2013833.","journal-title":"Intern Med J"},{"key":"8982_CR22","doi-asserted-by":"publisher","first-page":"S18","DOI":"10.14309\/01.ajg.0000723072.98473.28","volume":"115","author":"S Deloshaan","year":"2020","unstructured":"Deloshaan S, Pradeep KR, Dheeraj S, Hadi M, Maneesha B, Naveed I et al. P069 admission steroid use, serum albumin and endoscopic severity predict intravenous steroid failure in patients with acute severe ulcerative colitis. Off J Am College Gastroenterol. 2020;115:S18.","journal-title":"Official journal of the American College of Gastroenterology."},{"key":"8982_CR23","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1093\/ecco-jcc\/jjx084","volume":"11","author":"S Jain","year":"2017","unstructured":"Jain S, Kedia S, Bopanna S, Sachdev V, Sahni P, Dash NR et al. Faecal calprotectin and UCEIS predict short-term outcomes in acute severe colitis: prospective cohort study. J Crohns Colitis. 2017;11:1309\u20131316.","journal-title":"J Crohns Colitis"},{"key":"8982_CR24","doi-asserted-by":"crossref","first-page":"S266","DOI":"10.1093\/ecco-jcc\/jjaa091","volume":"14","author":"V Gupta","year":"2020","unstructured":"Gupta V, Mohsen W, Adams A, Murphy A, Sathananthan D, Cripps S et al. P241 Early prediction of outcome in acute severe ulcerative colitis (ASC): comparison of clinical and endoscopic indices at presentation, with day 3 criteria. J Crohn\u2019s Colitis. 2020;14:S266\u2013S266.","journal-title":"J Crohn\u2019s and Colitis."},{"key":"8982_CR25","doi-asserted-by":"publisher","first-page":"1132","DOI":"10.1111\/apt.13614","volume":"43","author":"RW Lynch","year":"2016","unstructured":"Lynch RW, Churchhouse AM, Protheroe A, Arnott ID. Predicting outcome in acute severe ulcerative colitis: comparison of the Travis and Ho scores using UK IBD audit data. Aliment Pharmacol Ther. 2016;43:1132\u20131141.","journal-title":"Aliment Pharmacol Ther"},{"key":"8982_CR26","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1007\/s10620-019-05668-6","volume":"65","author":"AC Moore","year":"2020","unstructured":"Moore AC, Bressler B. Acute severe ulcerative colitis: the oxford criteria no longer predict in-hospital colectomy rates. Dig Dis Sci. 2020;65:576\u2013580. https:\/\/doi.org\/10.1007\/s10620-019-05668-6","journal-title":"Dig Dis Sci"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-08982-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10620-025-08982-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-025-08982-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,9,6]],"date-time":"2025-09-06T10:26:36Z","timestamp":1757154396000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10620-025-08982-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,5]]},"references-count":26,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["8982"],"URL":"https:\/\/doi.org\/10.1007\/s10620-025-08982-4","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,5]]},"assertion":[{"value":"16 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"SS has research grants from AbbVie, Pfizer, Takeda, Tillots Pharma, and Johnson & Johnson, has received consulting fees from Celltrion, BMS Takeda, AbbVie, Merck, Ferring, Pharmacocosmos, Warner Chilcott, Janssen, Falk Pharma, Biohit, TriGenix, Celgene, Lilly, and Tillots Pharma; has received payment or honoraria for lectures from AbbVie, Takeda, Celltrion, Pfizer, Biogen, AbbVie, Janssen, Merck, Warner Chilcott, Falk Pharma, Janssen, and Lilly.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"We declare that this manuscript has not been previously published or submitted to another journal.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}